The story of Viagra and the pharmaceutical industry presents a challenging picture for careful investors. Initially, copyright's hugely successful drug altered the treatment of erectile dysfunction, generating substantial profits and shaping the current pharmaceutical landscape. However, intellectual property expiration and the rise of generic vers